Acid Reflux Product Provides Relief with Top Rating from...

Nexium, a leading Acid Reflux product, receives the highest ranking available from February 22, 2019)Read the full story at
Source: PRWeb: Medical Pharmaceuticals - Category: Pharmaceuticals Source Type: news

Related Links:

AbstractPurpose of ReviewKnowledge regarding postoperative outcomes after bariatric and metabolic surgery continues to evolve. This review highlights key findings in outcomes research over the last 5  years related to weight loss, remission of obesity-related disease, reflux, revisional surgery, robotic-assisted surgical platforms, and adolescent populations.Recent FindingsSleeve gastrectomy (SG) and Roux-en-Y gastric bypass (RYGB) produce similar weight loss patterns at 5  years, while duodenal switch (BPD/DS) and related procedures are associated with maximal weight loss overall and optimal resolution of obesit...
Source: Current Obesity Reports - Category: Eating Disorders & Weight Management Source Type: research
ConclusionEndoscopy reports frequently do not include the use of a grading system for esophagitis or the Prague system for CLE. This hampers the assessment of change with therapy or over time. The size of a hiatal hernia was typically reported in a subjective fashion and only infrequently was the type specified. Lack of clarity about the presence of a paraesophageal hernia can impede evaluation of acute symptoms. In patients with Barrett ’s esophagus a standard biopsy protocol was infrequently reported to be used. These findings raise concern about the quality of upper endoscopy, both in the performance of the proced...
Source: Journal of Gastrointestinal Surgery - Category: Surgery Source Type: research
In this study we explore the efficacy and pharmacokinetics of rectally administered omeprazole in infants with gastroesophageal reflux disease (GERD) due to esophageal atresia (EA) or congenital diaphragmatic hernia (CDH) and compare these with orally administered omeprazole.MethodsInfants (6 –12 weeks postnatal and bodyweight>  3 kg) with EA or CDH and GERD were randomized to receive a single dose of 1 mg/kg omeprazole rectally or orally. The primary outcome was the percentage of infants for whom omeprazole was effective according to predefined criteria for 24-h intraesophageal pH. Secondary...
Source: European Journal of Drug Metabolism and Pharmacokinetics - Category: Drugs & Pharmacology Source Type: research
Every rheumatologist should be comfortable using a validated symptom scale for evaluating gastroesophageal reflux disease in patients with scleroderma, according to one expert.Medscape Medical News
Source: Medscape Medical News Headlines - Category: Consumer Health News Tags: Rheumatology News Source Type: news
The advent of antisecretory drugs, such H2-receptor antagonists (H2RAs) and proton pump inhibitors (PPIs), has revolutionized the management of acid-related diseases, leading to the virtual abolition of elective surgery for ulcer disease and relegating anti-reflux surgery to patients with reflux disease not adequately managed by medical therapy. PPIs remain the mainstay of medical treatment for gastro-esophageal reflux disease (GERD) [1 –3]. They act indirectly by reducing the amount and concentration of gastric secretion available for reflux, thus lessening the aggressive power of the refluxed material [4].
Source: Digestive and Liver Disease - Category: Gastroenterology Authors: Tags: Commentary Source Type: research
SPONSORED POST By SAM HOLLIDAY Medically reviewed by Jenny Blair, MD Gastrointestinal diseases like inflammatory bowel disease (IBD), gastroesophageal reflux disease (GERD), and irritable bowel syndrome (IBS) are more prevalent—and costlier—than many employers realize. Up to 70 million Americans are affected by gastrointestinal (GI) diseases each year—twice as many people as those living with diabetes (34.2 million).[1],[2] Overall direct healthcare costs for GI diseases are estimated to be $136 billion each year in the U.S., more than heart disease ($113bn) and mental health disorders ($99bn...
Source: The Health Care Blog - Category: Consumer Health News Authors: Tags: Health Tech gastrointestinal diseases Oshi Health Sam Holliday Source Type: blogs
Conclusions: Esomeprazole BD was as effective as esomeprazole OD in improving GERD-related NCCP. Although statistically insignificant, the percentage of patients with>50% reduction in the chest pain score was higher in the esomeprazole BD group than in the esomeprazole OD group. Large-scale studies will be needed to assess these findings further. PMID: 32581204 [PubMed - in process]
Source: Korean J Gastroenter... - Category: Gastroenterology Authors: Tags: Korean J Gastroenterol Source Type: research
Publication date: Available online 23 June 2020Source: Journal of Visceral SurgeryAuthor(s): D. Collet, C. Gronnier
Source: Journal of Visceral Surgery - Category: Surgery Source Type: research
Several recent studies in Clinical Gastroenterology and Hepatology have examined the effectiveness of alternative strategies in the management of difficult to treat gastroesophageal reflux disease.1,2 Anti-reflux surgery is also an effective therapy to control proton pump inhibitors (PPI)-refractory symptoms of regurgitation, which occurs in roughly 13% of gastroesophageal reflux disease patients. Magnetic sphincter augmentation (MSA) is an alternative to standard fundoplication that uses magnetic attraction from inside a series of titanium beads which are placed laparoscopically in a bracelet-like fashion around the lower...
Source: Clinical Gastroenterology and Hepatology - Category: Gastroenterology Authors: Tags: Issue Highlights Source Type: research
DISCUSSION: Women who had been hospitalized for severe AN reported more symptoms 10 years after treatment, implies psychological and somatic follow-up in the long term. LEVEL OF EVIDENCE: Level III, case-control analytic study. PMID: 32572843 [PubMed - as supplied by publisher]
Source: Eating and weight disorders : EWD - Category: Eating Disorders & Weight Management Authors: Tags: Eat Weight Disord Source Type: research
More News: Acid Reflux | Esomeprazole | Gastroesophageal Reflux Disease | GERD | Nexium | Pharmaceuticals